Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look. Scientists are rediscovering what many see as the substances’ astonishing therapeutic potential for a vast range of issues, from depression to drug addiction and acceptance of mortality.
{iframe}https://www.scientificamerican.com/article/johns-hopkins-scientists-give-psychedelics-the-serious-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=mind&utm_content=link&utm_term=2020-01-22_featured-this-week&spMailingID=62638444&spUserID=NTM5NzIyODE5NgS2&spJobID=1802893205&spReportId=MTgwMjg5MzIwNQS2{/iframe}